These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28385649)

  • 41. RNA interference by nanofiber-based siRNA delivery system.
    Cao H; Jiang X; Chai C; Chew SY
    J Control Release; 2010 Jun; 144(2):203-12. PubMed ID: 20138939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human-Based Biological and Biomimetic Autologous Therapies for Musculoskeletal Tissue Regeneration.
    Padilla S; Sánchez M; Orive G; Anitua E
    Trends Biotechnol; 2017 Mar; 35(3):192-202. PubMed ID: 28007307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance and applications of nanoparticles in siRNA delivery for cancer therapy.
    Ali HM; Urbinati G; Raouane M; Massaad-Massade L
    Expert Rev Clin Pharmacol; 2012 Jul; 5(4):403-12. PubMed ID: 22943120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development of novel biomaterials for bone and cartilage tissue engineering].
    Kawazoe N; Chen G; Tateishi T
    Clin Calcium; 2008 Dec; 18(12):1713-20. PubMed ID: 19043184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls.
    Aicher WK; Bühring HJ; Hart M; Rolauffs B; Badke A; Klein G
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):342-51. PubMed ID: 21184789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers.
    Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J
    Mol Pharm; 2013 Jun; 10(6):2435-44. PubMed ID: 23611705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.
    Santo VE; Gomes ME; Mano JF; Reis RL
    Nanomedicine (Lond); 2012 Jul; 7(7):1045-66. PubMed ID: 22846091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.
    Zhi D; Zhao Y; Cui S; Chen H; Zhang S
    Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?
    Oryan A; Kamali A; Moshiri A; Baghaban Eslaminejad M
    Cells Tissues Organs; 2017; 204(2):59-83. PubMed ID: 28647733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell sheet approach for tissue engineering and regenerative medicine.
    Matsuura K; Utoh R; Nagase K; Okano T
    J Control Release; 2014 Sep; 190():228-39. PubMed ID: 24858800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioprinting technology and its applications.
    Seol YJ; Kang HW; Lee SJ; Atala A; Yoo JJ
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):342-8. PubMed ID: 25061217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gold nanorod delivery of LSD1 siRNA induces human mesenchymal stem cell differentiation.
    Zhao X; Huang Q; Jin Y
    Mater Sci Eng C Mater Biol Appl; 2015 Sep; 54():142-9. PubMed ID: 26046277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage.
    Toh WS; Spector M; Lee EH; Cao T
    Mol Pharm; 2011 Aug; 8(4):994-1001. PubMed ID: 21500855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stem cell-based composite tissue constructs for regenerative medicine.
    Rahaman MN; Mao JJ
    Biotechnol Bioeng; 2005 Aug; 91(3):261-84. PubMed ID: 15929124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-Derived Extracellular Matrix: Basic Characteristics and Current Applications in Orthopedic Tissue Engineering.
    Zhang W; Zhu Y; Li J; Guo Q; Peng J; Liu S; Yang J; Wang Y
    Tissue Eng Part B Rev; 2016 Jun; 22(3):193-207. PubMed ID: 26671674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. siRNA as a tool to improve the treatment of brain diseases: Mechanism, targets and delivery.
    Gomes MJ; Martins S; Sarmento B
    Ageing Res Rev; 2015 May; 21():43-54. PubMed ID: 25796492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kidney regeneration and repair after transplantation.
    Franquesa M; Flaquer M; Cruzado JM; Grinyó JM
    Curr Opin Organ Transplant; 2013 Apr; 18(2):191-6. PubMed ID: 23425788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
    Mishra DK; Balekar N; Mishra PK
    Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteoarthritis year in review 2014: highlighting innovations in basic research and clinical applications in regenerative medicine.
    van Osch GJ
    Osteoarthritis Cartilage; 2014 Dec; 22(12):2013-6. PubMed ID: 25456296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.